Portal vein thrombosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
 
(12 intermediate revisions by one other user not shown)
Line 4: Line 4:
{{CMG}}; {{AE}} {{F.K}}
{{CMG}}; {{AE}} {{F.K}}
==Overview==
==Overview==
The [[incidence]] of portal vein thrombosis in [[cirrhosis]] patients is unknown. The [[prevalence]] of portal vein thrombosis is approximately 5000-10,000 per 100,000 in overall cases of [[portal hypertension]] in developed counties and 40,000 per 100,000 in developing countries. The overall [[mortality rate]] of portal vein thrombosis is less than 10% except for patients with [[malignancy]] or [[cirrhosis]]. Patients of all age groups may develop portal vein thrombosis. There is no racial predilection to portal vein thrombosis. Portal vein thrombosis affects men and women equally.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence of portal vein thrombosis in cirrhotic patients is unknown.<ref name="pmid20066733">{{cite journal |vauthors=Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolfi R, Gasbarrini A |title=Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment |journal=World J. Gastroenterol. |volume=16 |issue=2 |pages=143–55 |year=2010 |pmid=20066733 |pmc=2806552 |doi= |url=}}</ref>
*The [[incidence]] of portal vein thrombosis in [[cirrhosis]] patients is unknown.<ref name="pmid20066733">{{cite journal |vauthors=Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolfi R, Gasbarrini A |title=Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment |journal=World J. Gastroenterol. |volume=16 |issue=2 |pages=143–55 |year=2010 |pmid=20066733 |pmc=2806552 |doi= |url=}}</ref>


===Prevalence===
===Prevalence===
*The prevalence of portal vein thrombosis is approximately 5000-10,000 per 100,000 in overall cases of portal hypertension in developed counties and 40,000 per 100,000 in developing countries.<ref name="pmid20066733">{{cite journal |vauthors=Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolfi R, Gasbarrini A |title=Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment |journal=World J. Gastroenterol. |volume=16 |issue=2 |pages=143–55 |year=2010 |pmid=20066733 |pmc=2806552 |doi= |url=}}</ref>
*The [[prevalence]] of portal vein thrombosis is approximately 5000-10,000 per 100,000 in overall cases of [[portal hypertension]] in developed counties and 40,000 per 100,000 in developing countries.<ref name="pmid20066733">{{cite journal |vauthors=Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolfi R, Gasbarrini A |title=Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment |journal=World J. Gastroenterol. |volume=16 |issue=2 |pages=143–55 |year=2010 |pmid=20066733 |pmc=2806552 |doi= |url=}}</ref><ref name="pmid16610067">{{cite journal |vauthors=Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH |title=Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies |journal=World J. Gastroenterol. |volume=12 |issue=13 |pages=2115–9 |year=2006 |pmid=16610067 |pmc=4087695 |doi= |url=}}</ref>
*The prevalence of portal vein thrombosis is less than 1000 per 100,000 in patients with compensated cirrhosis, but is 8000-25000 per 100,000 in patients who are candidates for liver transplantation.<ref name="pmid4007419">{{cite journal |vauthors=Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, Musha H, Takashi M, Suzuki N, Shinagawa T |title=Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients |journal=Gastroenterology |volume=89 |issue=2 |pages=279–86 |year=1985 |pmid=4007419 |doi= |url=}}</ref><ref name="pmid15831918">{{cite journal |vauthors=Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F |title=Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation |journal=Gut |volume=54 |issue=5 |pages=691–7 |year=2005 |pmid=15831918 |pmc=1774501 |doi=10.1136/gut.2004.042796 |url=}}</ref>
*The [[prevalence]] of portal vein thrombosis is less than 1000 per 100,000 in patients with compensated [[cirrhosis]], but is 8000-25000 per 100,000 in patients who are candidates for [[liver transplantation]].<ref name="pmid4007419">{{cite journal |vauthors=Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, Musha H, Takashi M, Suzuki N, Shinagawa T |title=Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients |journal=Gastroenterology |volume=89 |issue=2 |pages=279–86 |year=1985 |pmid=4007419 |doi= |url=}}</ref><ref name="pmid15831918">{{cite journal |vauthors=Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F |title=Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation |journal=Gut |volume=54 |issue=5 |pages=691–7 |year=2005 |pmid=15831918 |pmc=1774501 |doi=10.1136/gut.2004.042796 |url=}}</ref><ref name="pmid18274708">{{cite journal |vauthors=Fimognari FL, Violi F |title=Portal vein thrombosis in liver cirrhosis |journal=Intern Emerg Med |volume=3 |issue=3 |pages=213–8 |year=2008 |pmid=18274708 |doi=10.1007/s11739-008-0128-0 |url=}}</ref>


===Case-fatality rate/Mortality rate===
===Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The overall [[mortality rate]] of portal vein thrombosis is less than 10% except for patients with [[malignancy]] or [[cirrhosis]].<ref name="pmid20066733">{{cite journal |vauthors=Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolfi R, Gasbarrini A |title=Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment |journal=World J. Gastroenterol. |volume=16 |issue=2 |pages=143–55 |year=2010 |pmid=20066733 |pmc=2806552 |doi= |url=}}</ref>
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
*The [[mortality rate]] of portal vein thrombosis in patients with [[malignancy]] or [[cirrhosis]] about 26%.<ref name="pmid25941431">{{cite journal |vauthors=Chawla YK, Bodh V |title=Portal vein thrombosis |journal=J Clin Exp Hepatol |volume=5 |issue=1 |pages=22–40 |year=2015 |pmid=25941431 |pmc=4415192 |doi=10.1016/j.jceh.2014.12.008 |url=}}</ref>
*In patients with chronic portal vein thrombosis one-year survival alters from 80% to 95%, and 3-year survival varies from 75% to 90%.<ref name="ParikhShah2010">{{cite journal|last1=Parikh|first1=Sameer|last2=Shah|first2=Riddhi|last3=Kapoor|first3=Prashant|title=Portal Vein Thrombosis|journal=The American Journal of Medicine|volume=123|issue=2|year=2010|pages=111–119|issn=00029343|doi=10.1016/j.amjmed.2009.05.023}}</ref>


===Age===
===Age===
*Patients of all age groups may develop [disease name].
*Patients of all age groups may develop portal vein thrombosis.<ref name="pmid20066733">{{cite journal |vauthors=Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolfi R, Gasbarrini A |title=Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment |journal=World J. Gastroenterol. |volume=16 |issue=2 |pages=143–55 |year=2010 |pmid=20066733 |pmc=2806552 |doi= |url=}}</ref>
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*The [[incidence]] of portal vein thrombosis increases with age and it commonly affects individuals 66-70 years in men and 69-74 years in women.<ref name="pmid16610067">{{cite journal |vauthors=Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH |title=Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies |journal=World J. Gastroenterol. |volume=12 |issue=13 |pages=2115–9 |year=2006 |pmid=16610067 |pmc=4087695 |doi= |url=}}</ref>
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
*There is no racial predilection to [disease name].
*There is no racial predilection to portal vein thrombosis.
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 
===Gender===
===Gender===
*[Disease name] affects men and women equally.
*Portal vein thrombosis affects men and women equally.<ref name="pmid16610067">{{cite journal |vauthors=Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH |title=Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies |journal=World J. Gastroenterol. |volume=12 |issue=13 |pages=2115–9 |year=2006 |pmid=16610067 |pmc=4087695 |doi= |url=}}</ref>
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
 
===Developed Countries===
 
===Developing Countries===


==References==
==References==

Latest revision as of 14:24, 29 December 2017

Portal vein thrombosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Portal vein thrombosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Portal vein thrombosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Portal vein thrombosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Portal vein thrombosis epidemiology and demographics

CDC on Portal vein thrombosis epidemiology and demographics

Portal vein thrombosis epidemiology and demographics in the news

Blogs on Portal vein thrombosis epidemiology and demographics

Directions to Hospitals Treating Portal vein thrombosis

Risk calculators and risk factors for Portal vein thrombosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

The incidence of portal vein thrombosis in cirrhosis patients is unknown. The prevalence of portal vein thrombosis is approximately 5000-10,000 per 100,000 in overall cases of portal hypertension in developed counties and 40,000 per 100,000 in developing countries. The overall mortality rate of portal vein thrombosis is less than 10% except for patients with malignancy or cirrhosis. Patients of all age groups may develop portal vein thrombosis. There is no racial predilection to portal vein thrombosis. Portal vein thrombosis affects men and women equally.

Epidemiology and Demographics

Incidence

Prevalence

Mortality rate

Age

  • Patients of all age groups may develop portal vein thrombosis.[1]
  • The incidence of portal vein thrombosis increases with age and it commonly affects individuals 66-70 years in men and 69-74 years in women.[2]

Race

  • There is no racial predilection to portal vein thrombosis.

Gender

  • Portal vein thrombosis affects men and women equally.[2]

References

  1. 1.0 1.1 1.2 1.3 Ponziani FR, Zocco MA, Campanale C, Rinninella E, Tortora A, Di Maurizio L, Bombardieri G, De Cristofaro R, De Gaetano AM, Landolfi R, Gasbarrini A (2010). "Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment". World J. Gastroenterol. 16 (2): 143–55. PMC 2806552. PMID 20066733.
  2. 2.0 2.1 2.2 Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH (2006). "Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies". World J. Gastroenterol. 12 (13): 2115–9. PMC 4087695. PMID 16610067.
  3. Okuda K, Ohnishi K, Kimura K, Matsutani S, Sumida M, Goto N, Musha H, Takashi M, Suzuki N, Shinagawa T (1985). "Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients". Gastroenterology. 89 (2): 279–86. PMID 4007419.
  4. Francoz C, Belghiti J, Vilgrain V, Sommacale D, Paradis V, Condat B, Denninger MH, Sauvanet A, Valla D, Durand F (2005). "Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation". Gut. 54 (5): 691–7. doi:10.1136/gut.2004.042796. PMC 1774501. PMID 15831918.
  5. Fimognari FL, Violi F (2008). "Portal vein thrombosis in liver cirrhosis". Intern Emerg Med. 3 (3): 213–8. doi:10.1007/s11739-008-0128-0. PMID 18274708.
  6. Chawla YK, Bodh V (2015). "Portal vein thrombosis". J Clin Exp Hepatol. 5 (1): 22–40. doi:10.1016/j.jceh.2014.12.008. PMC 4415192. PMID 25941431.
  7. Parikh, Sameer; Shah, Riddhi; Kapoor, Prashant (2010). "Portal Vein Thrombosis". The American Journal of Medicine. 123 (2): 111–119. doi:10.1016/j.amjmed.2009.05.023. ISSN 0002-9343.

Template:WH Template:WS